Effects of Ibudilast (MN-166, Formerly AV411), a Glial Activation Inhibitor, on Oxycodone Self-administration in Opioid Abusers
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Ibudilast (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- 06 Mar 2016 Results published in MediciNiva media release.
- 07 Feb 2016 According to a MediciNova media release, data from this trial will be presented at the Behavior, Biology and Chemistry Annual Meeting and Symposium 2016.
- 07 Feb 2016 According to a MediciNova media release, status changed from active, no longer recruiting to completed.